Please login to the form below

Not currently logged in


This page shows the latest BNT162b2 news and features for those working in and with pharma, biotech and healthcare.

Pfizer/BioNTech’s COVID-19 vaccine is 100% effective in adolescents

Pfizer/BioNTech’s COVID-19 vaccine is 100% effective in adolescents

The results come from a phase 3 trial of the vaccine – known as BNT162b2 – in adolescents aged 12 to 15 years old, with or without prior evidence of SARS-CoV-2 ... This study will evaluate the efficacy and safety of BNT162b2 as a two-dose schedule in

Latest news

More from news
Approximately 5 fully matching, plus 52 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Want to give perfect client service? Tough luck, you’re human
In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....